<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<title>BRIDG Release 1.0 -- Static Classes::StudyProtocol</title>
<link href="../../../../css/ea.css" rel="stylesheet" type="text/css" />
<script>
function initPage(src) {
	if(parent==this&&(this.location+"").indexOf('EARoot')!=-1)
		document.location=(this.location+"").substring(0,(this.location+"").indexOf('EARoot'))+"index"+(this.location+"").substring((this.location+"").lastIndexOf('.'))+"?goto="+((this.location+"").substring((this.location+"").indexOf('EARoot')+7,(this.location+"").lastIndexOf('.')).replace(/\//g,':').replace(/EA/g,""));
	else
		parent.initPage(src);
}
</script>
</head>
<body onload="initPage(this);" class="Content">
<div class="pageHeader"></div>
<div class="PageBody">
	<span class="ObjectTitle">StudyProtocol  : public   &lt;&lt;Release 1.0&gt;&gt; class</span>
	<table border="0" cellpadding="0" cellspacing="0" class="ObjectDetails">
		<tr>
			<td width="15%" class="ObjectDetailsTopic">Created:</td>
			<td width="85%" class="ObjectDetailsValue">3/14/2005 4:52:38 PM</td>
		</tr>
		<tr>
			<td class="ObjectDetailsTopic">Modified:</td>
			<td class="ObjectDetailsValue">6/18/2007 3:18:39 PM</td>
		</tr>
		<tr style="height: 10px"><td colspan="2"></td></tr>
		<tr>
			<td class="ObjectDetailsTopic"><img src="../../../../images/plus03.gif" align="absmiddle" id="proj" onclick="parent.toggleData(this.id)" />Project:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj00" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Author:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj01" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Version:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj02" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Phase:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj03" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Status:</td>
			<td class="ObjectDetailsValue">Release 1.0</td>
		</tr>
		<tr id="proj04" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Complexity:</td>
			<td class="ObjectDetailsValue">Easy</td>
		</tr>
		<tr>
			<td class="ObjectDetailsTopic"><img src="../../../../images/plus03.gif" align="absmiddle" id="adv" onclick="parent.toggleData(this.id)" />Advanced:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="adv00" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">UUID:</td>
			<td class="ObjectDetailsValue">{792E71ED-0AD4-4eaf-A499-8AFB57DB3E62}</td>
		</tr>
		<tr id="adv01" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Appears In:</td>
			<td class="ObjectDetailsValue"><a href="EA528.htm">View 4 -  BRIDG Study Performed View</a>, <a href="EA522.htm">View 1 - BRIDG Focus - Protocol-driven Research</a>, <a href="EA532.htm">View 6 - BRIDG Backbone - Part 2</a>, <a href="EA536.htm">View 8 - Complete BRIDG View - classes with local attributes</a>, <a href="EA524.htm">View 2 - BRIDG Study Planned View</a>, <a href="EA534.htm">View 7 - Complete BRIDG View - Classes Only</a>, <a href="EA538.htm">View 9 - Complete BRIDG View - Classes,  Attributes,  Inheritance</a></td>
		</tr>
	</table>
	<div class="ObjectDetailsNotes">&lt;p&gt;This class is defined as &lt;&lt;both&gt;&gt; a subtype of Documentation - meaning that the term is used to define, specify, and/or contain any number of the specific documents that describe the objective(s), background, and/or plan (including the design, methodology, statistical considerations, organization, or other supplemental materials that describe the required information of a PlannedStudy &lt;&lt;and&gt;&gt; a collector for the specifications of specific activities, observations, interventions or assessments that are planned in a PlannedStudy&#160; or executed in a PerformedStudy.&#160; This includes all activities planned to test a particular hypothesis that is the basis of the StudyProtocol regarding the therapeutic effectiveness of a particular treatment, drug, device, procedure, or system.&#160; A StudyProtocol can be either Primary or Correlative.&#160; A StudyProtocol is considered to be Primary if it has one or more Correlative studies associated with it.&#160; A Correlative study extends the objectives or observations/conclusions of a Primary study, enrolling the same (or a subset of the same) subjects as were enrolled in the Primary study.&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;A document that describes the objective(s), background and plan (including design, methodology, statistical considerations and organization) of a Planned Study. The protocol also may refer to supplemental materials that describe required information. [modified ICH]&#160; &lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;NOTE: We are assuming that a document is a container, which may be physical or logical, with the six characteristics listed in the definition of the Document class.&#160; This class is the container for the Plan. &lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;NOTE: StudyProtocol describes the pre-study, study, and post-study portions of the plan.&lt;br/&gt;&lt;/p&gt;</div>

	<div class="TableGroup" id="TableGroup">
		<ul class="ItemTitle">
			<li onClick="parent.toggleItem('Attributes');" id="AttributesTitle">Attributes</li>
			<li onClick="parent.toggleItem('AssociationsFrom');" id="AssociationsFromTitle">Associations From</li>
			<li onClick="parent.toggleItem('Links');" id="LinksTitle">Other Links</li>
		</ul>
<div class="ItemBody" id="AttributesTable">
	<table border="0" cellspacing="0" cellpadding="0" class="Table">
		<tr>
			<td width="40%" class="TableHeading">Attribute</td>
			<td width="60%" class="TableHeading">Details</td>
		</tr>
						<tr>
				<td width="40%" class="TableRow" valign="top"><i>public <a href="EA572.htm">CD</a></i><br /><strong>&nbsp;&nbsp;disease</strong></td>
				<td width="60%" class="TableRow" valign="top"><i>Alias:</i> Protocol Disease Code<br><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Code to represent the condition that is the focus of the study. &lt;br /&gt;For example, in a study to examine risk factors for Lupus, might have as an inclusion criterion &quot;healthy volunteer&quot;, but the targetConditionCode would be a Lupus SNOMED code.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public <a href="EA572.htm">CD</a></i><br /><strong>&nbsp;&nbsp;phase</strong></td>
				<td width="60%" class="TableRow" valign="top"><i>Alias:</i> Protocol Phase Code<br><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Coded designation of phase for a clinical trial. For example,&nbsp;<WBR> I, I/II, II, III, NA.&lt;br /&gt;&lt;br /&gt;Clinical trials are generally categorized into four (sometimes five) phases described separately herein. An investigational medicine or product may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. &lt;br /&gt;&lt;br /&gt;Phase 1: The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects.&nbsp;<WBR> &lt;br /&gt;Phase 2: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug.&lt;br /&gt;Phase 3: Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. &lt;br /&gt;Phase 3b: Phase 3b studies are a sub category of phase 3 trials near the time of approval to elicit additional findings.&lt;br /&gt;Phase 4:&nbsp;<WBR> Concurrent with marketing approval, FDA may seek agreement from the sponsor to conduct certain postmarketing (phase 4) studies to delineate additional information about the drug&#39;s risks, benefits, and optimal use. &lt;br /&gt;Phase 5: Postmarketing surveillance is sometimes referred to as Phase 5.&lt;br /&gt;[CDISC glossary v345 -- derived from the FDA definitions]
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public <a href="EA572.htm">CD</a></i><br /><strong>&nbsp;&nbsp;intent</strong></td>
				<td width="60%" class="TableRow" valign="top"><i>Alias:</i> Protocol Type Code<br><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Codes to identify a type of protocol based upon its intent (genetic, diagnostic, preventive, etc.).&nbsp;<WBR> For example, D-Diagnostic Protocol, GN-Genetic Non-therapeutic Protocol, etc.&lt;br /&gt;&lt;br /&gt;For example,Treatment trials test new treatments, new combinations of drugs, or new approaches to surgery or radiation therapy. Prevention trials look for better ways to prevent disease in people who have never had the disease or to prevent a disease from returning. These approaches may include medicines, vitamins, vaccines, minerals, or lifestyle changes. Diagnostic trials are conducted to find better tests or procedures for diagnosing a particular disease or condition. Screening trials test the best way to detect certain diseases or health conditions. Quality of Life trials (or Supportive Care trials) explore ways to improve comfort and the quality of life for individuals with a chronic illness.&nbsp;<WBR> (NIH) [CDISC glossary]&lt;br /&gt;The kind of study. This is an enumerated type. For example, types might be interventional, observational, quality of life trials, prevention trials, and correlative.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public string</i><br /><strong>&nbsp;&nbsp;populationDescription</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Provides a text summary of subject characteristics, including inclusion and exclusion criteria and describes the population for which the study may be generalized. Textual summary of the target study population. This would be a more general description that would include all subgroups as well.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public <a href="EA572.htm">CD</a></i><br /><strong>&nbsp;&nbsp;subjectType</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The target entity of the study of investigation. For example, in a clinical trial, the subject type would be &quot;human&quot;. Other studies could involve animals (rats, mice). 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public boolean</i><br /><strong>&nbsp;&nbsp;blindedIndicator</strong></td>
				<td width="60%" class="TableRow" valign="top"><i>Alias:</i> Protocol Blinding Indicator<br><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Indicator of Yes (Y) or No (N) to specify if a protocol is blinded.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public <a href="EA572.htm">CD</a></i><br /><strong>&nbsp;&nbsp;blindingSchema</strong></td>
				<td width="60%" class="TableRow" valign="top"><i>Alias:</i> Protocol Blinding Indicator<br><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The type of masking used on a trial to ensure that the results are not biased by the subjects or investigators.&lt;br /&gt;&lt;br /&gt;For example, double-blinded would indicate that both the investigator and the participant would not know whether the intervention was a placebo or a active therapeutic intervention. This will be drawn from a coded list of terms that define the blinding type. &lt;br /&gt;&lt;br /&gt;For example, Open Label, Double Blind, Single Blind, etc.. 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public boolean</i><br /><strong>&nbsp;&nbsp;multiInstitutionIndicator</strong></td>
				<td width="60%" class="TableRow" valign="top"><i>Alias:</i> Multi-Institutional Protocol Indicator<br><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			A Yes/No response to indicate if a protocol is being conducted at more than one site concurrently.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public boolean</i><br /><strong>&nbsp;&nbsp;randomizedIndicator</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			An indicator as to whether a study is randomized.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public <a href="EA572.htm">CD</a></i><br /><strong>&nbsp;&nbsp;confidentiality</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			A code that controls the disclosure of information about this Document, regardless of BusinessProcessMode.&nbsp;<WBR> The confidentialityCode can be interpreted on a role-specific basis and therefore can facilitate role-based access control strategies.&nbsp;<WBR> However it does not specify them.&nbsp;<WBR> Likewise it does not specify masking or related strategies but can be used to facilitate their implementation.&nbsp;<WBR> &lt;br /&gt;&lt;br /&gt;NOTE: This attribute comes from the CDISC PR elements spreadsheet [CDISC]
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public <a href="EA572.htm">CD</a></i><br /><strong>&nbsp;&nbsp;monitor</strong></td>
				<td width="60%" class="TableRow" valign="top"><i>Alias:</i> Protocol Monitor Protocol Monitor Code<br><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Code to represent the monitor for a protocol. For example, CTEP, CTEP-CTMS, CTEP-CDUS Complete, etc.
		</td>
	</tr>
</table></div>
</td>
			</tr>
		</table>
</div>		<div class="ItemBody" id="AssociationsFromTable">
			<table border="0" cellspacing="0" cellpadding="0" class="Table">
				<tr>
					<td width="20%" class="TableHeading">Element</td>
					<td width="25%" class="TableHeading">Source Role</td>
					<td width="25%" class="TableHeading">Target Role</td>
					<td width="30%" class="TableHeading">Details</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA659.htm">«Release 1.0» StudyAuthor</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA658.htm">«Release 1.0» StudyAgent</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA576.htm">«Release 1.0» Documentation</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA662.htm">«Release 1.0» StudySite</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA556.htm">«Release 1.0» StudySponsor</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA660.htm">«Release 1.0» StudyInvestigator</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top">&nbsp;</td>
				</tr>

			</table>
		</div>
		<div class="ItemBody" id="LinksTable">
			<table align="center" border="0" cellspacing="0" cellpadding="0" class="Table">
				<tr>
					<td width="30%" class="TableHeading">Object</td>
					<td width="15%" class="TableHeading">Type</td>
					<td width="15%" class="TableHeading">Connection</td>
					<td width="40%" class="TableHeading">Notes</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA576.htm">«Release 1.0» Documentation</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Strong</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA576.htm">«Release 1.0» Documentation</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Generalization</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA642.htm">«Release 1.0» PerformedStudy</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Generalization</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA648.htm">«Release 1.0» PlannedStudy</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Generalization</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>

			</table>
		</div>
	</div>
<div class="pageFooter"></div>
 
</body>
</html>